Balance of benefit and risk of ticagrelor in patients with diabetes and stable coronary artery disease according to bleeding risk assessment with the CRUSADE score: Data from THEMIS and THEMIS PCI.

Balance of benefit and risk of ticagrelor in patients with diabetes and stable coronary artery disease according to bleeding risk assessment with the CRUSADE score: Data from THEMIS and THEMIS PCI. Am Heart J. 2022 07; 249:23-33.

View in: PubMed

subject areas

Coronary Artery Disease
Diabetes Mellitus
Hemorrhage
Humans
Myocardial Infarction
Percutaneous Coronary Intervention
Platelet Aggregation Inhibitors
Risk Assessment
Stroke
Treatment Outcome

authors with profiles

Robert Harrington